Matin Voegtli

Novartis (NYSE: NVS) is looking to decrease its American workforce in a move that will find almost 2,000 looking for work. Citing the loss of its patent for blood pressure drug Diovan, the firm said it will lower its American work force by 1,630 positions immediately, with another 330 jobs to be...